James R Meyers Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James R Meyers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James R Meyers. James R Meyers is EVP Worldwide Commercial Ops in GILEAD SCIENCES INC ($GILD) and SVP Comm Ops North America in GILEAD SCIENCES INC ($GILD) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Director in Arbutus Biopharma Corp ($TKMR) and Director in CytomX Therapeutics, Inc. ($CTMX).
Latest Insider Trading Transactions of James R Meyers
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TKMR, CTMX, GILD, SGMO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
Jun 19 2020 | CTMX | CytomX Therapeutic ... | Meyers James R | Director | Option Exercise | A | 8.35 | 20,000 | 167,000 | 20,000 | |
Jun 01 2020 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 9.81 | 30,000 | 294,300 | 30,000 | |
Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Aug 20 2019 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
Jun 21 2019 | CTMX | CytomX Therapeutic ... | Meyers James R | Director | Option Exercise | A | 11.31 | 14,000 | 158,340 | 14,000 | |
Dec 27 2018 | CTMX | CytomX Therapeutic ... | Meyers James R | Director | Option Exercise | A | 14.04 | 28,000 | 393,120 | 28,000 | |
Oct 22 2018 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 4.71 | 44,000 | 207,240 | 44,000 | |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,323 | 0 | 132,083 | 129.8 K to 132.1 K (+1.79 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,323 | 0 | 5,393 | 7.7 K to 5.4 K (-30.11 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 80.69 | 1,647 | 132,896 | 7,716 | 9.4 K to 7.7 K (-17.59 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,581 | 0 | 9,363 | 7.8 K to 9.4 K (+20.32 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 4,846 | 0 | 7,782 | 2.9 K to 7.8 K (+165.05 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 62.35 | 221 | 13,779 | 2,936 | 2.7 K to 2.9 K (+8.14 %) |
Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | A | 83.49 | 75,490 | 6,302,660 | 75,490 | |
Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 21.58 | 100,000 | 2,157,500 | 0 | |
Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 80.99 | 24,843 | 2,012,097 | 2,715 | 27.6 K to 2.7 K (-90.15 %) |
Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 80.00 | 75,157 | 6,012,267 | 27,558 | 102.7 K to 27.6 K (-73.17 %) |
Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 21.58 | 100,000 | 2,157,500 | 102,715 | 2.7 K to 102.7 K (+3,683.24 %) |
Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 1,327 | 0 | 129,760 | 128.4 K to 129.8 K (+1.03 %) |
Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 1,327 | 0 | 2,715 | 4 K to 2.7 K (-32.83 %) |
Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 73.02 | 1,373 | 100,256 | 4,042 | 5.4 K to 4 K (-25.36 %) |
Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 2,700 | 0 | 5,415 | 2.7 K to 5.4 K (+99.45 %) |
Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 0.00 | 4,500 | 0 | 4,460 | |
Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,288 | 0 | 128,433 | 126.1 K to 128.4 K (+1.81 %) |
Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,288 | 0 | 2,715 | 5 K to 2.7 K (-45.73 %) |
Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 73.46 | 2,212 | 162,494 | 5,003 | 7.2 K to 5 K (-30.66 %) |
Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 0.00 | 4,500 | 0 | 7,215 | 2.7 K to 7.2 K (+165.75 %) |
Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 21.00 | 60,000 | 1,260,000 | 0 | |
Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 83.64 | 16,700 | 1,396,775 | 2,715 | 19.4 K to 2.7 K (-86.02 %) |
Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 83.01 | 43,300 | 3,594,515 | 19,415 | 62.7 K to 19.4 K (-69.04 %) |
Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 21.00 | 60,000 | 1,260,000 | 62,715 | 2.7 K to 62.7 K (+2,209.94 %) |
Aug 31 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 115 | 0 | 126,145 | 126 K to 126.1 K (+0.09 %) |
Aug 31 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 115 | 0 | 2,715 | 2.8 K to 2.7 K (-4.06 %) |
Aug 31 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 59.76 | 115 | 6,873 | 2,830 | 2.7 K to 2.8 K (+4.24 %) |
Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 0.00 | 820 | 0 | 8,960 | |
Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 525 | 0 | 126,030 | 125.5 K to 126 K (+0.42 %) |
Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 525 | 0 | 2,715 | 3.2 K to 2.7 K (-16.20 %) |
Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 72.70 | 295 | 21,447 | 3,240 | 3.5 K to 3.2 K (-8.35 %) |
Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 0.00 | 820 | 0 | 3,535 | 2.7 K to 3.5 K (+30.20 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 4,354 | 0 | 125,505 | 121.2 K to 125.5 K (+3.59 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 4,354 | 0 | 2,715 | 7.1 K to 2.7 K (-61.59 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 70.31 | 2,053 | 144,346 | 7,069 | 9.1 K to 7.1 K (-22.51 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,022 | 0 | 9,122 | 8.1 K to 9.1 K (+12.62 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,161 | 0 | 8,100 | 6.9 K to 8.1 K (+16.73 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 59.33 | 213 | 12,637 | 6,939 | 6.7 K to 6.9 K (+3.17 %) |
Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | A | 72.25 | 42,390 | 3,062,678 | 42,390 | |
Dec 13 2016 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | A | 72.70 | 28,040 | 2,038,508 | 28,040 | |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | M | 7.40 | 9,000 | 66,587 | 7,300 | |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.24 | 300 | 24,972 | 1,029 | 1.3 K to 1 K (-22.57 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.23 | 200 | 16,646 | 1,329 | 1.5 K to 1.3 K (-13.08 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.22 | 400 | 33,288 | 1,529 | 1.9 K to 1.5 K (-20.74 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.21 | 800 | 66,568 | 1,929 | 2.7 K to 1.9 K (-29.31 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.20 | 500 | 41,600 | 2,729 | 3.2 K to 2.7 K (-15.48 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.19 | 900 | 74,871 | 3,229 | 4.1 K to 3.2 K (-21.80 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.18 | 1,172 | 97,487 | 4,129 | 5.3 K to 4.1 K (-22.11 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.17 | 2,015 | 167,588 | 5,301 | 7.3 K to 5.3 K (-27.54 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.16 | 1,313 | 109,189 | 7,316 | 8.6 K to 7.3 K (-15.22 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.15 | 200 | 16,630 | 8,629 | 8.8 K to 8.6 K (-2.27 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.14 | 300 | 24,942 | 8,829 | 9.1 K to 8.8 K (-3.29 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.13 | 400 | 33,252 | 9,129 | 9.5 K to 9.1 K (-4.20 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.12 | 200 | 16,624 | 9,529 | 9.7 K to 9.5 K (-2.06 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 83.09 | 300 | 24,927 | 9,729 | 10 K to 9.7 K (-2.99 %) |
Apr 26 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Buy | M | 7.40 | 9,000 | 66,587 | 10,029 | 1 K to 10 K (+874.64 %) |
Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | M | 9.34 | 3,000 | 28,031 | 15,712 | |
Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | M | 7.08 | 3,000 | 21,235 | 0 | |
Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 71.35 | 6,000 | 428,088 | 1,029 | 7 K to 1 K (-85.36 %) |
Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Buy | M | 9.34 | 3,000 | 28,031 | 7,029 | 4 K to 7 K (+74.46 %) |
Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Buy | M | 7.08 | 3,000 | 21,235 | 4,029 | 1 K to 4 K (+291.55 %) |
Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | A | 65.58 | 35,000 | 2,295,300 | 35,000 | |
Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | A | 65.58 | 28,000 | 1,836,240 | 28,000 |
Page: 1